Madrigal Letterhead]Indemnification Agreement • July 22nd, 2016 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • Pennsylvania
Following the execution of the Merger Agreement and prior to the Trigger Date, as defined below (the “Effective Date”), you will devote 50% of your working attention serving in an interim role serving as President reporting to the Board of Directors of Madrigal (the “Board”). Following the satisfaction of all conditions precedent to closing the Merger under the Merger Agreement, for which Madrigal agrees to give you prompt written notice at the email address listed above, and immediately prior to the effective date of the Merger (collectively, the “Trigger Date”), you will serve as full-time Chief Executive Officer of Madrigal, reporting to the Board. Effective as of the Trigger Date, you will be elected by the Board as Chairman of the Board.
INDEMNIFICATION AGREEMENTIndemnification Agreement • July 22nd, 2016 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of , 20 by and between Madrigal Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement.
